UB Paderborn / Katalog / Suche / in CDI

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

The oncologist (Dayton, Ohio), 2012-01, Vol.17 (1), p.15-25

2012

Link zum Volltext

Verfügbarkeit prüfen

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1271-e128

2018

Link zum Volltext

Verfügbarkeit prüfen

Magnetic Resonance Diffusion as Predictive Value of Response to Treatment with Chemo-Radiotherapy in Patients with Locally Advanced Rectal Cancer

Annals of oncology, 2014-06, Vol.25, p.ii103-ii103

2014

Link zum Volltext

Verfügbarkeit prüfen

P-0256 Phase II Study to Evaluate Efficacy and Safety of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer (MCRC) Patients

Annals of oncology, 2012-06, Vol.23, p.iv103-iv104

2012

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

BMC cancer, 2015-04, Vol.15 (1), p.327-327, Article 327

2015

Link zum Volltext

Verfügbarkeit prüfen

Púrpura cutánea en relación con tamoxifeno

Clinical & translational oncology, 2004-06, Vol.6 (5), p.321-321

2004

Link zum Volltext

Verfügbarkeit prüfen

Simplified application of the model prognosis GERCOR group patients with metastatic colorectal cancer treated with bevacizumab

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14631-e14631

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for complications of Peripherally Catheters Central Insertion (PICC) of prolonged use in patients with solid tumors treated with chemotherapy

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20731-e20731

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of the localization of the primary tumor in the survival of patients with metastatic colon-rectal cancer treated with bevacizumab

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.665-665

2014

Link zum Volltext

Verfügbarkeit prüfen

Neumonía por Pneumocystis carinii y cáncer de órgano sólido

Revista de oncología (Barcelona, Spain), 2001-07, Vol.3 (4), p.222-223

2001

Link zum Volltext

Verfügbarkeit prüfen

Prognostic analysis according to the expression of hormone receptors in HER2-positive breast cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11075-e11075

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in metastatic colorectal cancer (mCRC) patients

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.501-501, Article 501

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

Magnetic Resonance Diffusion as Predictive Value of Response to Treatment with Chemo-Radiotherapy in Patients with Locally Advanced Rectal Cancer

P-0256 Phase II Study to Evaluate Efficacy and Safety of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer (MCRC) Patients

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

Púrpura cutánea en relación con tamoxifeno

Simplified application of the model prognosis GERCOR group patients with metastatic colorectal cancer treated with bevacizumab

Risk factors for complications of Peripherally Catheters Central Insertion (PICC) of prolonged use in patients with solid tumors treated with chemotherapy

Influence of the localization of the primary tumor in the survival of patients with metastatic colon-rectal cancer treated with bevacizumab

Neumonía por Pneumocystis carinii y cáncer de órgano sólido

Prognostic analysis according to the expression of hormone receptors in HER2-positive breast cancer

Phase II study to evaluate efficacy and safety of irinotecan, capecitabine, and bevacizumab in metastatic colorectal cancer (mCRC) patients

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Suchergebnisse filtern